NOV 21, 2018 10:23 AM PST

Yin and Yang of Malaria

WRITTEN BY: Nicholas Breehl

Does the timing of exposure to malaria as an infant affect the onset of disease later in life? A team of researchers at the Barcelona Institute for Global Health (IS Global) has identified a sort of yin and yang balance of cytokine immune modulators at two years of age that can protect against clinical malaria in early childhood.

Malaria is a mosquito-borne disease caused by a parasite. People with sickness often experience fever, chills, and flu-like illness. Left untreated, they may develop severe complications and die. In 2016 an estimated 216 million cases of malaria occurred worldwide, and 445,000 people died, mostly children in the African Region.

About 1,700 cases of malaria are diagnosed in the United States each year. The vast majority of cases in the United States are in travelers and immigrants returning from countries where malaria transmission occurs, many from sub-Saharan Africa and South Asia.

The effect of timing of exposure to first malarial infections during early childhood on the induction of innate and adaptive cytokine responses and their contribution to the development of clinical malaria immunity is not well established. For this reason, the team sought to determine what is happening.

In this study, Carlota Dobaño and her team evaluated whether the cytokines produced in the first two years after birth affect the risk of subsequent malaria. They also analyzed whether the timing of parasite exposure alters the cytokine response.

The study consisted of over 300 infants from Magrara in southern Mozambique. Of the 300 one cohort received preventative treatment while the others did not. Production of cytokines from the white blood cells was observed at various times until age 2. Clinical malarial infections were also recorded but until age 4.

The results show that a pro-inflammatory signature (IL-1, IL-6 and TNF cytokines) followed by an anti-inflammatory (IL-10 cytokine) signature between the first and second year of life is associated with a lower risk of clinical malaria between ages 3 and 4. "This makes sense, since IL-10 suppresses excessive inflammation," explains Dobaño.

The authors of the study share that it is essential for a balance -yin, and yang - of proinflammatory and anti-inflammatory cytokine signatures be present to provide clinical immunity during childhood.

Sources: Clinical Infectious Diseases, Science Daily, CDC, YouTube

About the Author
You May Also Like
SEP 11, 2020
Immunology
Could a Drug for Cats Treat COVID?
SEP 11, 2020
Could a Drug for Cats Treat COVID?
Canadian researchers have discovered that a drug used to treat coronavirus infections in cats shows promise in helping C ...
SEP 17, 2020
Coronavirus
A Biomarker May Predict the Most Severe COVID-19 Cases
SEP 17, 2020
A Biomarker May Predict the Most Severe COVID-19 Cases
Researchers may have found a way to identify the COVID-19 patients that will need targeted therapies the most.
NOV 17, 2020
Immunology
6 Injections a Year Prevent HIV Infections
NOV 17, 2020
6 Injections a Year Prevent HIV Infections
Last year, around 1.7 million people became infected with HIV, with around half of these being women. Encouraging result ...
NOV 16, 2020
Immunology
Measles Is Back and COVID Isn't Helping
NOV 16, 2020
Measles Is Back and COVID Isn't Helping
Measles is a highly contagious and airborne viral disease. There is no treatment besides supportive care once a person b ...
NOV 20, 2020
Drug Discovery & Development
Cat Parasite Gives Clues on New Drug Targets for Schizophrenia
NOV 20, 2020
Cat Parasite Gives Clues on New Drug Targets for Schizophrenia
Researchers from the UK and France have discussed a mechanism of action behind the infamous Toxoplasma gondii  ...
NOV 24, 2020
Drug Discovery & Development
MMR Vaccine Shows Promise Against COVID-19
NOV 24, 2020
MMR Vaccine Shows Promise Against COVID-19
Researchers have found that a vaccine used for mumps, measles, and rubella (MMR) may be effective in protecting against ...
Loading Comments...